Hypertension, Vol 14, 629-635, Copyright © 1989 by American Heart Association
XP Yang, OA Carretero, G Jacobsen and AG Scicli
Intracerebroventricular infusion of the peptide melittin increases
immunoreactive kinins in the cerebrospinal fluid of anesthetized dogs,
probably secondary to activation of brain or cerebrospinal fluid
kininogenases. Intracerebroventricular melittin also increases blood
pressure and heart rate, possibly mediated by brain kinins, since
intracerebroventricular bradykinin also increases blood pressure and heart
rate. We tested whether the effects of centrally administered melittin on
blood pressure and heart rate could be blocked by simultaneous infusion of
a kinin receptor antagonist, [DArg0]Hyp3- Thi5,8[DPhe7]bradykinin, in
normotensive awake rats. In the controls, intracerebroventricular infusion
of kinin receptor antagonist given for 1 hour at a rate of 10 micrograms/hr
blocked bradykinin-induced increases in blood pressure and heart rate by
80%. Basal blood pressure and heart rate were not affected by the kinin
receptor antagonist alone. After a 30-minute infusion of melittin (8
micrograms/30 min), cerebrospinal fluid kininogenase activity (n = 17) rose
from 0.13 +/- 0.05 to 0.43 +/- 0.1 ng/ml/min (p less than 0.02). Although
cerebrospinal fluid kinins increased from below sensitivity (0.02 ng/ml, n
= 12) to 0.19 +/- 0.1 ng/ml (n = 17), this change was due to drastic
increases in three rats, whereas in 12 of them kinins were below
sensitivity. Incubation of bradykinin (10 ng) with 0.1 ml rat cerebrospinal
fluid for 5 minutes destroyed 70% of kinins, suggesting that rapid
destruction may have made detection of increased CSF kinins
difficult.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Role of endogenous brain kinins in the cardiovascular response to intracerebroventricular melittin
Department of Medicine, Henry Ford Hospital, Detroit, Michigan 48202.
This article has been cited by other articles:
![]() |
H. E. De Wardener The Hypothalamus and Hypertension Physiol Rev, October 1, 2001; 81(4): 1599 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Madeddu, P. P. Parpaglia, N. Glorioso, L. Chao, and J. Chao Antisense Inhibition of the Brain Kallikrein-Kinin System Hypertension, December 1, 1996; 28(6): 980 - 987. [Abstract] [Full Text] |
||||
![]() |
I. M. Khan, D. H. Miller, J. Strickland, H. S. Margolius, and P. J. Privitera Brain Kallikrein-Kinin System Abnormalities in Spontaneously Hypertensive Rats Hypertension, April 1, 1995; 25(4): 524 - 530. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |